Interest in {dimethyltryptamine | copyright | this substance ) is increasingly fueling a notable conversation across Canada. Until recently viewed as the periphery of exploration, copyright is now attracting wider scrutiny from researchers , practitioners , and the community. Regulatory frameworks s